true 0001419051 0001419051 2024-05-31 2024-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 31, 2024

 

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
(Exact Name of Registrant as Specified in its Charter)

 

Nevada   000-54554   45-1226465

(State or other jurisdiction of

incorporation or organization)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification Number)

 

701 Wild Rose Lane
Elk City, Idaho 83525
(Address of Principal Executive Offices and Zip Code)
 
(760) 295-7208
(Issuer’s telephone number)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   TSOI   OTC Markets

 

 

 

 
 

 

Explanatory Note

 

We provided the board minutes originally instead of attaching the license agreement.

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement

 

On May 30, 2024, Therapeutic Solutions International, Inc. licensed partially owned subsidiary Campbell Neurosciences, Inc. entered into an exclusive patent license agreement included here in exhibit 10.1.

 

Item 8.01 Other Events.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference including reference to exhibits.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit Index

 

(10.1) Exclusive Patent License Agreement between TSOI and CNSI Patent Publication No. 20220280574.
   
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 31, 2024

 

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.  
     
By: /s/ Timothy Dixon  
  Timothy Dixon  
  Chief Executive Officer  

 

 

 

Exhibit 10.1

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 

 

 

 

v3.24.1.1.u2
Cover
May 31, 2024
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Amendment Description We provided the board minutes originally instead of attaching the license agreement.
Document Period End Date May 31, 2024
Entity File Number 000-54554
Entity Registrant Name THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Entity Central Index Key 0001419051
Entity Tax Identification Number 45-1226465
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 701 Wild Rose Lane
Entity Address, City or Town Elk City
Entity Address, State or Province ID
Entity Address, Postal Zip Code 83525
City Area Code 760
Local Phone Number 295-7208
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol TSOI
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Therapeutic Solutions (PK) Charts.
Therapeutic Solutions (PK) (USOTC:TSOI)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Therapeutic Solutions (PK) Charts.